B-cell prolymphocytic leukemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Jun 2022Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Sumithira Vasu — PHASE1

TrialRECRUITING
Sep 2014Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

City of Hope Medical Center — PHASE1

TrialACTIVE NOT RECRUITING
Dec 2013Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
May 2012PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

Kami Maddocks, MD — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for B-cell prolymphocytic leukemia.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials
2Phase 2
2Phase 1
4Total recruiting
Search clinical trials for B-cell prolymphocytic leukemia

Recent News & Research

No recent news articles indexed yet for B-cell prolymphocytic leukemia.
Search PubMed for B-cell prolymphocytic leukemia

Browse all B-cell prolymphocytic leukemia news →

Specialist Network

Top 6 by expertise

View all B-cell prolymphocytic leukemia specialists →

Quick Actions